• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

PREDICTION OF DRUG DISPOSITION BY HUMAN DRUG METABOLIZING ENZYMES

Research Project

Project/Area Number 11557191
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section展開研究
Research Field 医薬分子機能学
Research InstitutionKANAZAWA UNIVERSITY

Principal Investigator

YAMAZAKI Hiroshi  KANAZAWA UNIVERSITY, FACULTY OF PHARMACEUTICAL SCIENCES, 薬学部, 助教授 (30191274)

Co-Investigator(Kenkyū-buntansha) YOKOI Tsuyoshi  KANAZAWA UNIVERSITY, FACULTY OF PHARMACEUTICAL, 薬学部, 教授 (70135226)
SHIMADA Noriaki  DAIICHI PURE CHEMICALS, GENERAL MANEGAER, 素材技術研究所, 所長(研究職)
NAKAJIMA Miki  KANAZAWA UNIVERSITY, FACULTY OF PHARMACEUTICAL SCIENCES, ASSISTANT PROFESSOR, 薬学部, 助手 (70266162)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥4,700,000 (Direct Cost: ¥4,700,000)
Fiscal Year 2000: ¥4,700,000 (Direct Cost: ¥4,700,000)
KeywordsP450 / human liver microsomes / phenytoin / tegafur / Individual difference / P450 contents / coexpressing system / drug Interaction / チトクロムP450 / CYP3A4 / 組換えヒトP450 / NADPH-P450還元酵素 / チトクロームb5 / 大腸菌 / テストステロン
Research Abstract

Drug oxidation activities of twelve recombinant human cytochrome P450 (P450) coexpressed with human NADPH-P450 reductase (NPR) in bacterial membranes (P450/NPR membranes) were determined and compared with those of other recombinant systems and of human liver microsomes. Addition of exogenous membrane-bound NPR to the P450/NPR membranes enhanced the catalytic activities of CYP2C8, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 ; however, enhancement of activities of CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2D6, and CYP2E1 in membranes was not observed after the addition of NPR in 4-molar excess to each P450. Exogenous purified human cytochrome b_5 (b_5) further enhanced catalytic activities of CYP2A6, CYP2B6, CYP2C8, CYP2E1, CYP3A4, and CYP3A5/NPR membranes. Catalytic activities of CYP2C9 and CYP2C19 were enhanced by addition of b_5 in reconstitution systems but not in the P450/NPR membranes. Apo b_5 (devoid of heme) enhanced catalytic activities when added to the both systems, except for CYP2E1/NPR membranes and the reconstituted systems containing purified CYP2C8 or CYP2E1 in comparison with b_5. Catalytic activities in P450/NPR membranes plus b_5 systems were roughly similar to those measured with microsomes of insect cells coexpressing P450 with NPR (and b_5) and/or of human liver microsomes, based on equivalent P450 contents. These results suggest that interactions of P450 and NPR coexpressed in membranes and reconstituted systems appear to be different in some human CYP2 family enzymes, possibly due to a conformational role of b_5. P450/NPR membrane systems containing b_5 are useful models for prediction of the rates for liver microsomal P450-dependent drug oxidations.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Komatsu,T. et al.: "Formation of a dihydroxy metabolite of phenytoin by human liver microsomes/cytosol : roles of cytochrome P450 2C9, 2C19, and 3A4"Drug Metab.Dispos.. 28. 1361-1368 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Komatsu,T. et al.: "Roles of cytochrome P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anti-cancer prodrug, in human liver microsomes"Drug Metab.Dispos.. 28. 1457-1463 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohyama,K. et al.: "A significant role of human cytochrome P450 (CYP) 2C8 in amiodarone and N-deethylation : an approach to predect the contribution with reactive activity factor (RAF)"Drug Metab.Dispos.. 28. 1303-1310 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Inoue,K. et al.: "CYP2A6 genetic polymorphism and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians"Arch.Toxicol... 73. 532-539 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamazaki,H. et al.: "In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes : comparison with pioglitazone and rosiglitazone"Xenobiotica. 30. 61-70 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 山崎浩史: "ヒトチトクロムP450の薬物代謝学・毒性学的研究"薬学雑誌. 120. 1347-1357 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Komatsu, T.et al.: "Formation of a dihydroxy metabolite of phenytoin by human liver microsomes/cytosol : roles of cytochrome P450 2C9, 2C19, and 3A4"Drug Metab. Dispos.. 28. 1361-1368 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Komatsu, T.et al.: "Roles of cytochrome P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes"Drug Metab. Dispos.. 28. 1457-1463 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohyama, K.et al.: "A significant role of human cytochrome P450 (CYP) 2C8 in amiodarone and N-deethylation : an approach to predect the contribution with reactive activity factor (RAF)"Drug Metab. Dispos.. 28. 1303-1310 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Inoue, K.et al.: "CYP2A6 genetic polymorphism and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians"Arch.Toxicol.. 73. 532-539 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamazaki, H.et al.: "In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes : comparison with pioglitazone and rosiglitazone"Xenobiotica. 30. 61-70 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamazaki, H.: "Roles of human cytochrome P450 enzymes involved in drug metabolism and toxicological studies."J.Pharm.Soc.J.. 120. 1347-1357 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Komatsu,T. et al.: "Formation of a dihydroxy metabolite of phenytoin by human liver microsomes/cytosol : roles of cytochrome P450 2C9, 2C19, and 3A4"Drug Metab.Dispos.. 28. 1361-1368 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Komatsu,T. et al.: "Roles of cytochrome P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anti-cancer prodrug, in human liver microsomes"Drug Metab.Dispos.. 28. 1457-1463 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ohyama,K. et al.: "A significant role of human cytochrome P450 (CYP) 2C8 in amiodarone and N-deethylation : an approach to predect the contribution with reactive activity factor (RAF)"Drug Metab.Dispos.. 28. 1303-1310 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Inoue,K. et al.: "CYP2A6 genetic polymorphism and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians"Arch.Toxicol... 73. 532-539 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamazaki,H. et al.: "In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes : comparison with piolitazone and rosiglitazone"Xenobiotica. 30. 61-70 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 山崎浩史: "ヒトチトクロムP450の薬物代謝学・毒性学的研究"薬学雑誌. 120. 1347-1357 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamazaki H,et al.: "Enhancement of cytochrome P4503A4 catalytic activities by cytochrome b5 in bacterial membranes"Drug Metab Dispos. 27. 999-1004 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Nakajima M,et al.: "Azelastine N-demethylation by CYP3A4, CYP2D6, and CYP1A2 in human liver microsomes: Evaluation of approach to predict the contribution of multiple cytochrome P450s"Drug Metab Dispos. 27. 1381-1391 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Nakajima M,et al.: "Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes"Drug Metab Dispos. 27. 792-797 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Nakajima M,et al.: "Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds"Xenobiotica. 29. 1191-1202 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yamazaki H,et al.: "Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P450 2C8 and P450 3A4 in human liver microsomes"Drug Metab Dispos. 27. 1260-1266 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Shimada T,et al.: "Prediction of human microsomal oxidations of 7-ethoxycoumarin and chlozoxazone using kinetic parameters of recombinat cytochrome P450 enzymes"Drug Metab Dispos. 27. 1274-1280 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi